ArticleJournal of surgical case reports2026
Clinical consequences of delayed recognition of gastrointestinal basidiobolomycosis: a case series.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal basidiobolomycosis (GIB) is a rare infection that often mimics colorectal malignancy or inflammatory bowel disease, leading to delayed diagnosis. A 20-year-old man presented with acute right iliac fossa pain and imaging suggestive of a cecal carcinoma with hepatic metastases. Colonoscopy showed a large fungating cecal mass, and biopsies demonstrated necrotizing granulomatous inflammation with broad pauciseptate hyphae compatible with basidiobolomycosis. A 14-year-old girl had mucous diarrhea, significant weight loss and was labeled as ulcerative colitis despite non-diagnostic histology, then developed mesalazine-related hypokalemia with cardiac arrest. Abdominal magnetic resonance imaging at a tertiary centre showed severe rectosigmoid colitis with peritoneal disease, and omental biopsy confirmed GIB. Both patients were treated with prolonged voriconazole. The first had complete clinical and radiologic resolution of colonic and hepatic disease without surgery. The second had marked regression of rectosigmoid and peritoneal disease, with later radiologic recurrence of pelvic disease despite ongoing therapy, but remains clinically stable under multidisciplinary follow-up. This series highlights GIB as an important differential diagnosis for refractory colitis in immunocompetent patients and supports the use of voriconazole as an organ-sparing option when the diagnosis is made before complications develop.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.